WebHologic has now acquired Biotheranostics, developer of two highly differentiated molecular diagnostic tests for breast and metastatic cancers – Breast Cancer Index™ (BCI) and … WebFor Breast Cancer Index Intended Use and Limitations, visit the full site. Biotheranostics, Inc., A Hologic Company. 6333 Sequence Dr., San Diego, CA 92121. 1 (877) 886-6739.
Hologic Completes Acquisition of Biotheranostics, Enabling Entry …
Webbiotheranostics, inc. A HOLOGIC COMPANY Breast Cancer Index™ (BCI), performed by Biotheranostics, Inc., is the only test that is guideline-recognized to predict extended … WebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in … Biotheranostics Nondiscrimination Statement. Biotheranostics, Inc. … the gang\u0027s all here wow
BioTheranostics Stock Price, Funding, Valuation, Revenue
WebThis test is used for clinical purposes, and should not be regarded as experimental or investigational. How this information is used to guide patient care is the responsibility of the treating provider. Biotheranostics is certified under the Clinical Laboratory Improvement Amendments of 1988 to perform high complexity clinical laboratory testing. WebJan 6, 2024 · Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second tuck-in for the medical device maker less than a week into 2024. The deal is expected to close in February. Biotheranostics is a privately-held company that sells molecular diagnostics tests for breast and metastatic cancers. Hologic said the ... WebJul 18, 2016 · Au 30 juin 2016, le chiffre d’affaires de bioMérieux a atteint 1 001 millions d’euros contre 933 millions d’euros au 30 juin 2015, soit une hausse à données publiées de 7,2 %, intégrant des effets de change négatifs de 26 millions d’euros environ, auxquels s’ajoute un effet de périmètre lié à la déconsolidation de ... the american center for law and justice